Salon, Sharmaine C.
HRN: 21-82-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2022
CO-AMOXICLAV 625MG (TAB)
08/27/2022
09/03/2022
PO
500mg
Q12
S/P NSD; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes